Myocardial tumor necrosis factor–α expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support
Open Access
- 31 December 2001
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 72 (6), 2044-2050
- https://doi.org/10.1016/s0003-4975(01)03172-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart FailureCell Metabolism, 2001
- The implications for cardiac recovery of left ventricular assist device support on myocardial collagen contentThe American Journal of Surgery, 2000
- Decreased Expression of Tumor Necrosis Factor-α in Failing Human Myocardium After Mechanical Circulatory SupportCell Metabolism, 1999
- Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart FailureCirculation, 1998
- Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated CardiomyopathyCirculation, 1997
- Improved Left Ventricular Function After Chronic Left Ventricular UnloadingThe Annals of Thoracic Surgery, 1996
- Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human HeartCell Metabolism, 1996
- Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart FailureCirculation, 1995
- Improved survival after extended bridge to cardiac transplantationThe Annals of Thoracic Surgery, 1994
- Implantation Technique for the HeartMateRLeft Ventricular Assist DeviceJournal of Cardiac Surgery, 1992